• Explore /
  • Poster
  • / Induction treatment in first-line with chemotherapy + bevacizumab (bev) in metastatic colorectal cancer: Results from the gercor-DREAM phase III study.

Induction treatment in first-line with chemotherapy + bevacizumab (bev) in metastatic colorectal cancer: Results from the gercor-DREAM phase III study.

Abstract Poster

Authors

null

Christophe Tournigand

Hopital Henri Mondor

Christophe Tournigand , Werner Scheithauer , Benoit Samson , Gérard Lledo , Frédéric Viret , Thierry Andre , Jean François Ramée , Nicole Tubiana-Mathieu , Jérôme Dauba , Olivier Dupuis , Yves Rinaldi , May Mabro , Nathalie Aucoin , Ahmed Khalil , Jean Latreille , Christophe Louvet , David Brusquant , Franck Bonnetain , Benoist Chibaudel , Aimery De Gramont

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT00265824

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr457)

DOI

10.1200/jco.2013.31.4_suppl.457

Abstract #

457

Poster Bd #

C13

Abstract Disclosures

Similar Posters

First Author: T. Hansen

First Author: Stefano Cascinu

First Author: Kentaro Yamazaki

First Author: Benoit Samson